Genasense oblimerson: Phase III data

In a Phase III trial in 241 patients, Genasense in combination with chemotherapy increased

Read the full 149 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE